NUVL

Nuvalent, Inc.NASDAQHealthcare

$105.43-0.20%ClosedMarket Cap: $7.72B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-27	Cantor Fitzgerald	—	Overweight	—
2025-12-19	JP Morgan	—	Overweight	—
2025-11-18	Baird	—	Outperform	—
2025-11-18	Guggenheim	—	Buy	—
2025-11-18	Goldman Sachs	—	Buy	—
2025-11-17	Leerink Partners	—	Outperform	—
2025-11-17	HC Wainwright & Co.	—	Buy	—
2025-11-17	Stifel	—	Buy	—
2025-10-31	UBS	—	Buy	—
2025-10-31	Barclays	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-4.24	$186.4M	13
Sun Dec 31	$-0.93	$528.6M	13
Mon Dec 31	$3.01	$919.6M	11
Tue Dec 31	$4.69	$1.21B	5